Increased stability of phosphatase and tensin homolog by intermedin leading to scavenger receptor A inhibition of macrophages reduces atherosclerosis in apolipoprotein E-deficient mice

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 4, 2012, Pages 509-520

  Dai, Xiao Yan ^a   Cai, Yan ^a   Mao, Ding Ding ^a   Qi, Yong Fen ^a   Tang, Chaoshu ^a   Xu, Qingbo ^b   Zhu, Yi ^a   Xu, Ming Jiang ^a   Wang, Xian ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Macrophage; Peptide; Scavenger receptor

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; INTERMEDIN; INTERMEDIN RECEPTOR ANTAGONIST; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RECEPTOR BLOCKING AGENT; SCAVENGER RECEPTOR A; SHORT HAIRPIN RNA; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CELL LEVEL; CONTROLLED STUDY; ENZYME STABILITY; FOAM CELL; GENE EXPRESSION REGULATION; IN VITRO STUDY; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR BLOCKING;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELLS, CULTURED; CHOLESTEROL; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FOAM CELLS; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDES; PHOSPHORYLATION; PROTEIN STABILITY; PTEN PHOSPHOHYDROLASE; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SCAVENGER RECEPTORS, CLASS A;

MUS;

EID: 84865569236     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.07.006     Document Type: Article

References (45)

1. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., et al. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation Feb 23 2010, 121(7):948-954.
2. Bobryshev Y.V. Monocyte recruitment and foam cell formation in atherosclerosis. Micron 2006, 37(3):208-222.
3. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med Apr 6 1989, 320(14):915-924.
4. Krieger M., Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 1994, 63:601-637.
5. Matsumoto A., Naito M., Itakura H., Ikemoto S., Asaoka H., Hayakawa I., et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A Dec 1990, 87(23):9133-9137.
6. Platt N., Gordon S. Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale. J Clin Invest Sep 2001, 108(5):649-654.
7. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature Mar 20 1997, 386(6622):292-296.
8. Sakaguchi H., Takeya M., Suzuki H., Hakamata H., Kodama T., Horiuchi S., et al. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab Invest Apr 1998, 78(4):423-434.
9. Babaev V.R., Gleaves L.A., Carter K.J., Suzuki H., Kodama T., Fazio S., et al. Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler Thromb Vasc Biol Dec 2000, 20(12):2593-2599.
10. de Winther M.P., Gijbels M.J., van Dijk K.W., van Gorp P.J., suzuki H., Kodama T., et al. Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice. Atherosclerosis Jun 1999, 144(2):315-321.
11. Moore K.J., Kunjathoor V.V., Koehn S.L., Manning J.J., Tseng A.A., Silver J.M., et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest Aug 2005, 115(8):2192-2201.
12. Xu G., Watanabe T., Iso Y., Koba S., Sakai T., Nagashima M., et al. Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis. Circ Res Aug 28 2009, 105(5):500-510.
13. Makinen P.I., Lappalainen J.P., Heinonen S.E., Leppanen P., Lahteenvuo M.T., Aarnio J.V., et al. Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors. Cardiovasc Res Dec 1 2010, 88(3):530-538.
14. Hagemann T., Wilson J., Burke F., Kulbe H., Li N.F., Pluddemann A., et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol Apr 15 2006, 176(8):5023-5032.
15. Yang G., Addai J., Tian W.H., Frolov A., Wheeler T.M., Thompson T.C. Reduced infiltration of class A scavenger receptor positive antigen-presenting cells is associated with prostate cancer progression. Cancer Res Mar 15 2004, 64(6):2076-2082.
16. Christie R.H., Freeman M., Hyman B.T. Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease. Am J Pathol Feb 1996, 148(2):399-403.
17. Paresce D.M., Ghosh R.N., Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron Sep 1996, 17(3):553-565.
18. Nikolic D., Calderon L., Du L., Post S.R. SR-A ligand and M-CSF dynamically regulate SR-A expression and function in primary macrophages via p38 MAPK activation. BMC Immunol Jul 7 2011, 12:37.
19. Li J., Fu Q., Cui H., Qu B., Pan W., Shen N., et al. Interferon-alpha priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-alpha and atherosclerosis in lupus. Arthritis Rheum Feb 2011, 63(2):492-502.
20. Li K., Yao W., Zheng X., Liao K. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage. Cell Res Aug 2009, 19(8):1006-1017.
21. Ming Cao W., Murao K., Imachi H., Sato M., Nakano T., Kodama T., et al. Phosphatidylinositol 3-OH kinase-Akt/protein kinase B pathway mediates Gas6 induction of scavenger receptor a in immortalized human vascular smooth muscle cell line. Arterioscler Thromb Vasc Biol Oct 2001, 21(10):1592-1597.
22. Liao D., Wang X., Li M., Lin P.H., Yao Q., Chen C. Human protein S inhibits the uptake of AcLDL and expression of SR-A through Mer receptor tyrosine kinase in human macrophages. Blood Jan 1 2009, 113(1):165-174.
23. Xie C., Kang J., Chen J.R., Lazarenko O.P., Ferguson M.E., Badger T.M., et al. Lowbush blueberries inhibit scavenger receptors CD36 and SR-A expression and attenuate foam cell formation in ApoE-deficient mice. Food Funct Oct 14 2011, 2(10):588-594.
24. Tsai J.Y., Su K.H., Shyue S.K., Kou Y.R., Yu Y.B., Hsiao S.H., et al. EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1. Cardiovasc Res Dec 1 2010, 88(3):415-423.
25. Bell D., McDermott B.J. Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems. Br J Pharmacol Mar 2008, 153(Suppl. 1):S247-S262.
26. Cai Y., Xu M.J., Teng X., Zhou Y.B., Chen L., Zhu Y., et al. Intermedin inhibits vascular calcification by increasing the level of matrix gamma-carboxyglutamic acid protein. Cardiovasc Res Mar 1 2010, 85(4):864-873.
27. Takahashi N., Kawada T., Goto T., Kim C.S., Taimatsu A., Egawa K., et al. Abietic acid activates peroxisome proliferator-activated receptor-gamma (PPARgamma) in RAW264.7 macrophages and 3T3-L1 adipocytes to regulate gene expression involved in inflammation and lipid metabolism. FEBS Lett Aug 28 2003, 550(1-3):190-194.
28. Ravandi A., Kuksis A., Shaikh N.A. Glycated phosphatidylethanolamine promotes macrophage uptake of low density lipoprotein and accumulation of cholesteryl esters and triacylglycerols. J Biol Chem Jun 4 1999, 274(23):16494-16500.
29. Wang X., Trotman L.C., Koppie T., Alimonti A., Chen Z., Gao Z., et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell Jan 12 2007, 128(1):129-139.
30. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A Jan 1979, 76(1):333-337.
31. Vazquez F., Ramaswamy S., Nakamura N., Sellers W.R. Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol Jul 2000, 20(14):5010-5018.
32. Tolkacheva T., Boddapati M., Sanfiz A., Tsuchida K., Kimmelman A.C., Chan A.M. Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383. Cancer Res Jul 1 2001, 61(13):4985-4989.
33. Torres J., Pulido R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J Biol Chem Jan 12 2001, 276(2):993-998.
34. Wu W., Wang X., Zhang W., Reed W., Samet J.M., Whang Y.E., et al. Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells. J Biol Chem Jul 25 2003, 278(30):28258-28263.
35. Moore K.J., Freeman M.W. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol Aug 2006, 26(8):1702-1711.
36. Roh J., Chang C.L., Bhalla A., Klein C., Hsu S.Y. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem Feb 20 2004, 279(8):7264-7274.
37. Yang J.H., Jia Y.X., Pan C.S., Zhao J., Ouyang M., Yang J., et al. Effects of intermedin(1-53) on cardiac function and ischemia/reperfusion injury in isolated rat hearts. Biochem Biophys Res Commun Feb 18 2005, 327(3):713-719.
38. Teng X., Song J., Zhang G., Cai Y., Yuan F., Du J., et al. Inhibition of endoplasmic reticulum stress by intermedin(1-53) protects against myocardial injury through a PI3 kinase-Akt signaling pathway. J Mol Med (Berl) Dec 2011, 89(12):1195-1205.
39. Wolle S., Via D.P., Chan L., Cornicelli J.A., Bisgaier C.L. Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia. J Clin Invest Jul 1995, 96(1):260-272.
40. Wu H., Moulton K., Horvai A., Parik S., Glass C.K. Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene. Mol Cell Biol Mar 1994, 14(3):2129-2139.
41. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem May 29 1998, 273(22):13375-13378.
42. Usui H.K., Shikata K., Sasaki M., Okada S., Matsuda M., Shikata Y., et al. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation. Diabetes Feb 2007, 56(2):363-372.
43. Sever-Chroneos Z., Tvinnereim A., Hunter R.L., Chroneos Z.C. Prolonged survival of scavenger receptor class A-deficient mice from pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb) Dec 2011, 91(Suppl. 1):S69-S74.
44. Lu C., Hua F., Liu L., Ha T., Kalbfleisch J., Schweitzer J., et al. Scavenger receptor class-A has a central role in cerebral ischemia-reperfusion injury. J Cereb Blood Flow Metab Dec 2010, 30(12):1972-1981.
45. Oz H.S., Zhong J., de Villiers W.J. Pattern recognition scavenger receptors, SR-A and CD36, have an additive role in the development of colitis in mice. Dig Dis Sci Dec 2009, 54(12):2561-2567.